VERITS 7 ½ 02/01/23

Veritas Pharma Inc

Credit, Healthcare


Publicly listed companies mentioned herein: Carlyle Group LP/The (CG), CommVault Systems Inc (CVLT), JPMorgan Chase & Co (JPM), Symantec Corp (SYMC)

Highlights

The presenter is long Veritas bonds (VERITS 7 ½ 02/01/23) due to his optimism on the company’s recovery. The enterprise software company was acquired from Symantec by The Carlyle Group with the deal closing in Q1’16, which the presenter notes to have been a bad time for the market. The company’s first lien is valued at ~$3.5B split mostly between a term loan and a 7.5% secured bond. There is also an $800MM, 10.5% unsecured bond. He got involved in Summer 2018 when the first lien’s bond was trading in the “low-90s” and the unsecured bond was trading in the “low-80s.” Things turned around for the company and both bonds were trading at ~110, but then the company’s performance disappointed again and the bond values fell their current ~95 (secured bond) and ~86 (unsecured bond). In the next twelve months, the presenter expects the secured bond to be trading at par with a high teens total return percentage. He thinks this is a great value, as investors can create a position at 4.5x EBITDA when comps trade at 8x+. His expectation for the unsecured bond is also bullish, as he expects the bond to trade in the mid- to high-90s, representing 25% – 30% total return which can be created at 6x EBITDA.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.